Cakmak A, Baba F, Cakmak S, Shermatov K, Karazeybek H
Department of Pediatrics, Harran University School of Medicine, Sanliurfa, Turkey.
Minerva Pediatr. 2010 Dec;62(6):599-603.
The authors assessed the clinical efficacy, tolerability and safety of acitretin in a patient with ichthyosis. A newborn infant with ichthyosis who presented at birth with collodion baby appearance, was treated with acitretin. A moderate response to acitretin therapy (1 mg/kg/day) administered for 6 months was observed, with improvement in cutaneous lesions. Clinical improvement was achieved shortly after treatment. The treatment resulted in a satisfactory improvement in the skin condition of the case. The tolerance to the drug was good. Side effects were not observed. The oral acitretin treatment is efficient in severe congenital ichthyosis.
作者评估了阿维A在一名鱼鳞病患者中的临床疗效、耐受性和安全性。一名患有鱼鳞病的新生儿出生时表现为胶样婴儿外观,接受了阿维A治疗。观察到对阿维A治疗(1毫克/千克/天)持续6个月有中度反应,皮肤病变有所改善。治疗后不久临床症状就得到了改善。该治疗使该病例的皮肤状况得到了令人满意的改善。对该药物的耐受性良好。未观察到副作用。口服阿维A治疗对严重先天性鱼鳞病有效。